Background: Massive neurofilament conglomeration in motor neurons has been described to occur in the early stages of both familial and sporadic amyotrophic lateral sclerosis (ALS). Previously, neurofilament conglomerates were immunolabeled for both superoxide dismutase (SOD 1) and nitrotyrosine, suggesting the potential for oxidative nitration damage to neurofilament protein by peroxynitrite. Long-lived neurofilaments may also undergo modification by advanced glycation endproducts (AGEs) with concomitant generation of free radicals, including superoxide. This radical species may then react with nitric oxide to form the potent oxidant, peroxynitrite, which in turn can nitrate neurofilament protein. Such a glycated and nitrated neurofilament pro-
Introduction
The seminal pathologic feature of early amyotrophic lateral sclerosis (ALS), a disease of neuro-filament-rich neurons, is massive neurofilament conglomeration in motor neurons (1, 2) . The most extreme changes include the formation of axonal spheroids in lower motor neurons and conglomerates in upper motor neurons (3) . Both familial and sporadic ALS show these changes on histopathological examination (2, 4, 5) . The study of neurofilament conglomeration is critical for (9) (10) (11) (12) . Neurofilament aggregation is a chronic process that may also involve the time-dependent cross-linking of neurofilament protein by advanced glycation endproducts (AGEs). In macromolecules such as low-density lipoprotein, AGE formation has been associated with oxidative modification and free radical production in vitro (13) (14) (15) (30, 31) , pentosidine, and pyrraline (32) ]. The sources and working dilutions of the primary antibodies against AGEs and other antigens are summarized in Table 1 . Immunostaining for SOD 1, ubiquitin, and both phosphorylated and nonphosphorylated neurofilament subunits (light, NF-L; medium, NF-M; heavy, NF-H) for confirmation of neurofilament conglomeration was performed as previously reported (1 1, 12) . Preabsorption testing for each of the anti-AGE antibodies was per-formed as previously described (32) (33) (34) (35) . Antibody to AGE was incubated with respective antigen, AGE-BSA (bovine serum albumin) for monoclonal and AGE-RNase (ribonuclease) for polyclonal antibody, for I hr at 37°C at a concentration of 0.5-1 mg/ml. The preabsorbed complexes were removed by centrifugation at top speed for 30 min. The supernatant was applied to the known AGE-positive spinal cord and motor cortex sections and the procedure for immunohistochemistry carried out as usual. Background immunostaining was assessed by omission of the primary antibody as another test for a negative control.
Results SODI, ubiquitin, and neurofilament immunoreactivities were co-localized with axonal spheroids and conglomerates as previously reported, along with the metabolites and enzymes related to nitric oxide/cGMP cascades (11, 12). Immunoreactivities for all the AGEs tested were unequivocally intense and selective in both axonal spheroids (Fig. la, c) and conglomerates (Fig. Ib, d ), whereas staining in the perikarya and the neuropil were negligible or equal to that of the background. AGE immunoreactivities in glial cells were also negligible, as were ubiquitin-immunopositive hyaline inclusions. The distribution patterns and immunoreactivities with antibodies against the two different AGEs were similar ( Fig. la-d) , although the monoclonal antibody against the AGE (cypentidone/piperidineenolone) was most sensitive and selectively immunoreactive for neurofilament conglomerates with little background staining at a I :24,000 dilution. Negative controls for both polyclonal and monoclonal (rabbit IgG and mouse IgG) immuno staining are shown in Figure I e and If, respectively, after pre-absorption with corresponding antigen. Whereas the immunoreactivities for pyrraline were equally intense and selective for neurofilament conglomerates and axonal spheroids (Fig. 2a, b) , those for pentosidine were not as selective as pyrraline (Fig. 2d) . Ubiquitin immunoreactivity was most intense in hyaline inclusions (Fig. 2c, arrowhead) and axonal spheroids were modestly immunopositive as well, but the neuronal soma was immunonegative. No AGE immunoreactivity was detected in hyaline or Bunina inclusions. Co-localization of immunoreactivities of AGE with those of neurofilament subunits, especially of the nonphosphorylated NF-np (Fig. 2e) and NF-L-np (Fig. 2f) , was unequivocal. No qualitative difference was noted in the immunoreactivities of axonal spheroids and neurofilament conglomerates between familial and sporadic ALS cases. Although neurofilament conglomerates in Betz cells were far more frequently noted in the familial ALS cases, its sigificance could not be construed because of the small number of cases studied. No neuronal inclusions were encountered in motoneurons of the control case. The rare diffuse intraneuronal neurofilament deposits of aging were infrequently encountered in small cortical pyramidal neurons, but they appeared distinctly different from the conglomerates in ALS patients.
Discussion
The linkage of the SOD I gene mutation to chromosome 21q22 in a small fraction of patients with familial ALS suggests that aberrant oxidation or free radical production may be involved in the pathogenesis of this disease (8) . Oxidative modification of neurofilament protein may also playa role, according to the results of studies of transgenic mouse lines that overexpress human neurofilament subunits, and to data obtained with human SODI mutants in which neurofilament accumulation was observed, as was neuronal cytoskeletalopathy secondary to SOD 1-gained toxicity (21, (36) (37) (38) (39) (40) (41) (42) (43) . In a case of ALS with SOD I-induced toxicity, concurrent neurofilament disruption and accumulation were postulated to be a general mechanism for the pathogenesis of familial ALS (44) .
Neurofilaments consist of long-lived cytoskeletal proteins with a slow turnover rate, and both early and late (Maillard) AGEs form in neurofilaments obtained from patients with diabetes mellitus and diabetic polyneuropathy (45) (46) (47) (48) , normal aging (32, 49) , and Alzheimer's disease (35, 50) . Although the particular type of glycation damage affecting neurofilaments has not been well documented, the vulnerability of neurofilaments to modification by the AGEs pyrraline or pentosidine has been suggested as a likely mechanism for producing irreversible, proteinprotein cross-linking (47, 48) . Neurofilament protein subunits of both 200 kD (NF-H) and 160 kD (NF-M) have multiple repeat sequences of KSP (Lys-Ser-Pro) at their carboxyl termini, and these subunits would be potentially susceptible to glycation reactions that affect lysine residues. It is noteworthy that both phosphorylation and enzymatic glycosylation of serine and threonine residues within the head domain of neurofilament subunits are considered essential for the normal assembly of neurofilaments, and these processes may be disrupted by AGE formation (51) (52) (53) (54) (55) . AGE-modified proteins also can be degraded to yield reactive, low-molecular-weight AGE peptides that may further contribute to neurofilament damage and conglomeration, which is similar to what has been described for the reaction of AGE peptides with collagen or circulating low-density lipoprotein in vivo (30, 56, 57) .
The present study provides indirect evidence that AGE formation may precede oxidative damage to neurofilament protein causing conglomeration and cross-linking (53, 54) . Indeed, the intense expression of SOD 1 in neurofilament conglomerates and inclusions suggests that local production of superoxide may occur as a result of the glycation of neurofilament proteins (11, 12, 17) . The production of superoxide and other radicals has been described in vitro in model glycation systems (58) . Nitric oxide generation in motor neurons (which normally do not have the active enzyme for synthesizing nitric oxide) can be induced only by injuries such as axonotomy or avulsion (59) (60) (61) . Nitric oxide is also the only known biological molecule that is sufficiently reactive and produced in high enough local concentrations to compete with SOD1 for superoxide (9) . Peroxynitrite, the reaction product of superoxide and nitric oxide, a potent oxidant, may then further contribute to the post-translational damage of neurofilament proteins. Accordingly, both motor neuron injuries and glycation of neurofilament protein may trigger and perpetuate peroxynitrite toxicity and the irreversible formation of neurofilament conglomerates.
Three post-translational neurofilament protein modifications have thus far been implicated in ALS. They are nitration, hyperphosphorylation, and glycation, all of which have been associated with oxidative damage of neurofilament proteins (10, 47, 62) . Moreover, at least three major cytoplasmic proteolytic systems, balanced by their inhibitors, appear to be involved in the degradation of damaged neurofilament proteins (ubiquitin/ATP-dependent protease, serpin/ serine protease, and cystatin/cysteine protease) (2, 12) . The activities of these systems overlap one another and are functionally interrelated in vivo. By immunohistochemistry, up-regulation of protein-bound nitrotyrosine was recently demonstrated in the neurofilament conglomerates and axonal spheroids of motor neurons in ALS by labeling with nitrotyrosine antibody (11, 12, 23, 24) . Because of the abundance of tyrosine residues, the NF-L subunit may also be vulnerable to nitration by peroxynitrite, which is formed by nitric oxide and superoxide (9, 10) . Although a recent report (25) indicates that nitrotyrosine formation predominantly affects the free amino acid tyrosine and not tyrosine contained in protein residues, nitrated and glycated peptides may form small soluble "second-generation AGEs" that can further propagate protein and tissue damage (25, 50, 56) .
The formation of AGEs on neurofilament proteins by a direct chemical reaction involving substrates other than reducing sugars cannot be excluded, as pyrraline production or "pyrrolylation" by 2,5, hexanedione (63) or by f3-f3'-iminodipropionitrile (IDPN) (64) may be possible. AGE formation may also occur, at least in part, after conglomerates form, as these aggregates are long-lived in vivo and may accumulate a variety of secondary modifications over time (30) . In the present study, the most consistent and intense signals for AGE immunoreactivity co-localized with axonal spheroids and conglomerates. Investigation of toxic, second-generation AGE-peptides and recently identified AGE-specific receptors, which are abundantly distributed in bovine spinal motor neurons, is also warranted in ALS (34, 56, 65, 66) . Structural elucidation of the precise neurofilament modifications present in axonal spheroids and conglomerates may prove to be important in understanding the morphogenesis of the neuronal inclusions that characterize ALS.
